quisqualic acid has been researched along with Brain Disorders in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lehmann, JC; Procureur, D; Wood, PL | 1 |
Clark, AJ; Hastings, MH; Latimer, M; Stone, TW; Winn, P | 1 |
Everitt, BJ; Jones, GH; Marston, HM; Page, KJ; Robbins, TW; Ryan, CN | 1 |
Johnston, MV; McDonald, JW; Silverstein, FS; Uckele, J | 1 |
Fukuda, H; Kaijima, M; Nakai, H; Tanaka, T; Yonemasu, Y | 1 |
5 other study(ies) available for quisqualic acid and Brain Disorders
Article | Year |
---|---|
7-Chlorokynurenate prevents NMDA-induced and kainate-induced striatal lesions.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brain Diseases; Choline O-Acetyltransferase; Corpus Striatum; Dose-Response Relationship, Drug; Kainic Acid; Kynurenic Acid; Male; N-Methylaspartate; Quisqualic Acid; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Serine | 1993 |
A comparison of excitotoxic lesions of the basal forebrain by kainate, quinolinate, ibotenate, N-methyl-D-aspartate or quisqualate, and the effects on toxicity of 2-amino-5-phosphonovaleric acid and kynurenic acid in the rat.
Topics: 2-Amino-5-phosphonovalerate; Animals; Brain; Brain Diseases; Ibotenic Acid; Kainic Acid; Kynurenic Acid; Male; N-Methylaspartate; Quinolinic Acid; Quinolinic Acids; Quisqualic Acid; Rats | 1991 |
Comparative effects of quisqualic and ibotenic acid-induced lesions of the substantia innominata and globus pallidus on the acquisition of a conditional visual discrimination: differential effects on cholinergic mechanisms.
Topics: Animals; Basal Ganglia; Behavior, Animal; Biomechanical Phenomena; Brain Diseases; Conditioning, Psychological; Discrimination Learning; Globus Pallidus; Ibotenic Acid; Male; Oxadiazoles; Oxazoles; Parasympathetic Nervous System; Quisqualic Acid; Rats; Rats, Inbred Strains; Substantia Innominata; Visual Perception | 1989 |
HA-966 (1-hydroxy-3-aminopyrrolidone-2) selectively reduces N-methyl-D-aspartate (NMDA)-mediated brain damage.
Topics: Animals; Animals, Newborn; Aspartic Acid; Brain Diseases; Corpus Striatum; N-Methylaspartate; Oxadiazoles; Pyrrolidinones; Quisqualic Acid; Rats; Rats, Inbred Strains | 1989 |
Quisqualic acid-induced hippocampal seizures in unanesthetized cats.
Topics: Animals; Brain Diseases; Cats; Electroencephalography; Hippocampus; Oxadiazoles; Quisqualic Acid; Seizures | 1985 |